A detailed history of Thrivent Financial For Lutherans transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 213,990 shares of IMCR stock, worth $7.25 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
213,990
Previous 211,831 1.02%
Holding current value
$7.25 Million
Previous $14.5 Million 3.89%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$60.14 - $75.36 $129,842 - $162,702
2,159 Added 1.02%
213,990 $13.9 Million
Q4 2023

Feb 14, 2024

SELL
$42.85 - $69.5 $175,427 - $284,533
-4,094 Reduced 1.9%
211,831 $14.5 Million
Q3 2023

Nov 14, 2023

BUY
$49.5 - $66.6 $140,679 - $189,277
2,842 Added 1.33%
215,925 $11.2 Million
Q2 2023

Aug 14, 2023

SELL
$48.54 - $61.64 $192,897 - $244,957
-3,974 Reduced 1.83%
213,083 $12.8 Million
Q1 2023

May 17, 2023

BUY
$46.12 - $65.71 $151,688 - $216,120
3,289 Added 1.54%
217,057 $10.7 Million
Q4 2022

Feb 08, 2023

BUY
$45.51 - $65.08 $177,352 - $253,616
3,897 Added 1.86%
213,768 $12.2 Million
Q3 2022

Nov 14, 2022

SELL
$37.34 - $57.44 $5.96 Million - $9.17 Million
-159,633 Reduced 43.2%
209,871 $9.85 Million
Q2 2022

Aug 16, 2022

SELL
$25.46 - $37.72 $463,117 - $686,126
-18,190 Reduced 4.69%
369,504 $13.8 Million
Q1 2022

May 13, 2022

BUY
$18.94 - $34.29 $617,652 - $1.12 Million
32,611 Added 9.18%
387,694 $11.6 Million
Q4 2021

Feb 16, 2022

BUY
$27.58 - $40.0 $134,287 - $194,760
4,869 Added 1.39%
355,083 $12.2 Million
Q3 2021

Nov 15, 2021

BUY
$27.98 - $40.0 $39,172 - $56,000
1,400 Added 0.4%
350,214 $13 Million
Q2 2021

Aug 19, 2021

BUY
$32.22 - $41.5 $920,267 - $1.19 Million
28,562 Added 8.92%
348,814 $13.6 Million
Q1 2021

May 17, 2021

BUY
$36.3 - $56.34 $11.6 Million - $18 Million
320,252 New
320,252 $13.6 Million

Others Institutions Holding IMCR

About Immunocore Holdings plc


  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.49B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.